This inventor holds 3 USPTO granted patents. Top assignees: Spofa Spojene Podniky Pro Zdravotnickou, Spojene Podniky Prozdravotnickou Vyrobu (Spofa), Vyzkumng, Ustav Pro Farmacii a Biochemii, Statni Podnik. Active years: 1987-1993.
Location History:
- Prague, CZ (1987)
- Zvonkova, CZ (1990)
- Praha, CZ (1993)
Company Filing History:
1 out of 2 
1 out of 1 
1 out of 1 Years Active: 1987-1993
Title: Eva Maturova: Innovator in Pharmaceutical Chemistry
Introduction
Eva Maturova is a distinguished inventor based in Zvonkova, Czech Republic. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. Her work focuses on developing innovative compounds with therapeutic applications, particularly in anti-inflammatory and analgesic properties.
Latest Patents
One of her latest patents involves derivatives of 4-(2,4-difluorbiphenylyl)-2-methyl-4-oxobutanoic acid. This invention relates to substances characterized by specific chemical formulas, which exhibit anti-inflammatory properties that are comparable to or greater than the initial acid. These modifications enhance the therapeutic applications of the compounds. Another notable patent is for an etheric derivative of 4(3H)-quinazolinone, which is produced by reacting 4(3H)-quinazolinone with a fluorinated biphenyl compound. This derivative demonstrates significantly higher analgesic activity and lower acute toxicity compared to well-known pain relievers such as ibuprofen and paracetamol.
Career Highlights
Throughout her career, Eva Maturova has worked with several reputable organizations, including Spofa Spojene Podniky Pro Zdravotnickou and Vyzkumng, Ustav Pro Farmacii a Biochemii, Statni Podnik. Her experience in these institutions has allowed her to refine her expertise in pharmaceutical research and development.
Collaborations
Eva has collaborated with notable colleagues such as Jaroslava Grimova and Miroslav Kuchar, contributing to various projects that advance the field of pharmaceutical sciences.
Conclusion
Eva Maturova's innovative work in pharmaceutical chemistry has led to the development of compounds with significant therapeutic potential. Her contributions continue to impact the industry positively, showcasing her dedication to advancing medical science.